(Q38380065)

2 September 2017

1 reference

title

Polycystic ovary syndrome and insulin: our understanding in the past, present and future (English)

1 reference

polycystic ovary syndrome

2 September 2017

main subject

1 reference

1 reference

Stéphanie B Mayer

1

1 reference

2 September 2017

William S Evans

series ordinal

2

1 reference

2 September 2017

John E Nestler

series ordinal

3

1 reference

2 September 2017

publication date

1 March 2015

1 reference

2 September 2017

1 reference

2 September 2017

volume

11

1 reference

2 September 2017

issue

2

1 reference

2 September 2017

page(s)

137-149

1 reference

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

2 September 2017

cites work

1 reference

Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature

21 January 2018

1 reference

Incidence of polycystic ovaries and polycystic ovary syndrome amongst women in Melbourne, Australia

21 January 2018

1 reference

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

21 January 2018

1 reference

The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man.

21 January 2018

1 reference

Insulin resistance associated with androgen excess in women with autoantibodies to the insulin receptor

21 January 2018

1 reference

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

21 January 2018

1 reference

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

21 January 2018

1 reference

Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome

21 January 2018

1 reference

Primary amenorrhea associated with hirsutism, acanthosis nigricans, dermoid cysts of the ovaries and a new type of insulin resistance

21 January 2018

1 reference

Hyperinsulinemia in hyperthecosis of the ovaries.

21 January 2018

1 reference

Obesity, acanthosis nigricans, insulin resistance, and hyperandrogenemia: pediatric perspective and natural history

21 January 2018

1 reference

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome

21 January 2018

1 reference

Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome

21 January 2018

1 reference

Suppression of serum insulin level by diazoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy, nonobese women

21 January 2018

1 reference

The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.

21 January 2018

1 reference

Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes

21 January 2018

1 reference

Ovarian morphology and prevalence of polycystic ovary syndrome in Japanese women with type 1 diabetes mellitus

21 January 2018

1 reference

Insulin resistance in nonobese patients with polycystic ovarian disease

21 January 2018

1 reference

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

21 January 2018

1 reference

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

21 January 2018

1 reference

Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus

21 January 2018

1 reference

Glucose Intolerance, Insulin Resistance, and Hyperandrogenemia in First Degree Relatives of Women with Polycystic Ovary Syndrome

21 January 2018

1 reference

Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome

21 January 2018

1 reference

Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society.

21 January 2018

1 reference

Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

Assessment of impaired glucose tolerance prevalence with hemoglobin A₁c and oral glucose tolerance test in 252 Turkish women with polycystic ovary syndrome: a prospective, controlled study

21 January 2018

1 reference

Hemoglobin A1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndrome.

21 January 2018

1 reference

Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome.

21 January 2018

1 reference

Changes in glucose tolerance with metformin treatment in polycystic ovary syndrome: a retrospective analysis

21 January 2018

1 reference

Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study

21 January 2018

1 reference

Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome

21 January 2018

1 reference

Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome

21 January 2018

1 reference

Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome

21 January 2018

1 reference

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

21 January 2018

1 reference

Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome

21 January 2018

1 reference

Anthropometric and Biochemical Characteristics of Polycystic Ovarian Syndrome in South Indian Women Using AES-2006 Criteria

21 January 2018

1 reference

Impaired uterine perfusion associated with metabolic disorders in women with polycystic ovary syndrome

21 January 2018

1 reference

Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute spons

21 January 2018

1 reference

Mortality of women with polycystic ovary syndrome at long-term follow-up

21 January 2018

1 reference

Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study

21 January 2018

1 reference

Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

21 January 2018

1 reference

The management of infertility associated with polycystic ovary syndrome

21 January 2018

1 reference

Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome

21 January 2018

1 reference

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

21 January 2018

1 reference

Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity

21 January 2018

1 reference

Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome

21 January 2018

1 reference

Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

Metformin in polycystic ovary syndrome: systematic review and meta-analysis

21 January 2018

1 reference

Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome

21 January 2018

1 reference

Use of metformin in polycystic ovary syndrome: a meta-analysis

21 January 2018

1 reference

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

21 January 2018

1 reference

Metformin versus insulin for the treatment of gestational diabetes

21 January 2018

1 reference

Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy

21 January 2018

1 reference

Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study

21 January 2018

1 reference

Pharmacokinetics of metformin during pregnancy

21 January 2018

1 reference

Transfer of metformin into human milk

21 January 2018

1 reference

Breast size increment during pregnancy and breastfeeding in mothers with polycystic ovary syndrome: a follow-up study of a randomised controlled trial on metformin versus placebo

21 January 2018

1 reference

Fertility treatments and multiple births in the United States

21 January 2018

1 reference

Efficacy of combined metformin-letrozole in comparison with bilateral ovarian drilling in clomiphene-resistant infertile women with polycystic ovarian syndrome

21 January 2018

1 reference

Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial

21 January 2018

1 reference

Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/WHE.14.73

1 reference

2 September 2017

1 reference